A Aciclovir, Acycloguanosine, Zovirax, Acyclovir CEP of the European Pharmacopoeia monograph is often referred to as a Aciclovir, Acycloguanosine, Zovirax, Acyclovir Certificate of Suitability (COS). The purpose of a Aciclovir, Acycloguanosine, Zovirax, Acyclovir CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Aciclovir, Acycloguanosine, Zovirax, Acyclovir EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Aciclovir, Acycloguanosine, Zovirax, Acyclovir to their clients by showing that a Aciclovir, Acycloguanosine, Zovirax, Acyclovir CEP has been issued for it. The manufacturer submits a Aciclovir, Acycloguanosine, Zovirax, Acyclovir CEP (COS) as part of the market authorization procedure, and it takes on the role of a Aciclovir, Acycloguanosine, Zovirax, Acyclovir CEP holder for the record. Additionally, the data presented in the Aciclovir, Acycloguanosine, Zovirax, Acyclovir CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Aciclovir, Acycloguanosine, Zovirax, Acyclovir DMF.
A Aciclovir, Acycloguanosine, Zovirax, Acyclovir CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Aciclovir, Acycloguanosine, Zovirax, Acyclovir CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Aciclovir, Acycloguanosine, Zovirax, Acyclovir suppliers with CEP (COS) on PharmaCompass.